Re:AstraZeneca may have provided incomplete efficacy data NIAID
by IfOnlyYouKnew on Tuesday March 23, 2021 @12:40PM
(#26557037)
They reported earlier numbers that showed about 79 % effectiveness even though more data had come in in the meantime and overall effectiveness had dropped to about 69 %.
So the issue is that they've included too much data leading to (in the DSMB view) inaccurate efficacy rather than incomplete data.
Nonetheless this is a management failure on their part because any disagreement with the DSMB over which data to include should have taken place privately before publication of the results. For all I know they have good reason for including this older data but it's not a good look to have your DSMB disagree with you in public now.